Perineural invasion and associated pain in pancreatic cancer

被引：367

作者：

Bapat, Aditi A. ^{[1
]}

Hostetter, Galen ^{[2
]}

Von Hoff, Daniel D. ^{[1
]}

Han, Haiyong ^{[1
]}

机构：

[1] Translat Genom Res Inst, Clin Translat Res Div, Scottsdale, AZ 85259 USA

[2] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA

来源：

NATURE REVIEWS CANCER | 2011年 / 11卷 / 10期

基金：

美国国家卫生研究院;

关键词：

NERVE GROWTH-FACTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; CELL-ADHESION MOLECULE; FACTOR FAMILY-MEMBERS; CELIAC PLEXUS BLOCK; DORSAL-ROOT GANGLIA; IN-VITRO; DUCTAL ADENOCARCINOMA; PROGNOSTIC-FACTOR; TRPV1; EXPRESSION;

D O I：

10.1038/nrc3131

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Perineural invasion (PNI) is a prominent characteristic of pancreatic cancer. PNI is a process whereby cancer cells invade the surrounding nerves, thus providing an alternative route for metastatic spread and pain generation. PNI is thought to be an indicator of aggressive tumour behaviour and has been shown to correlate with poor prognosis of patients with pancreatic cancer. Recent studies demonstrated that some signalling molecules and pathways that are involved in PNI are also involved in pain generation. Targeting these signalling pathways has shown some promise in alleviating pain and reducing PNI, which could potentially improve treatment outcomes for patients with pancreatic cancer.

引用

页码：695 / 707

页数：13

共 166 条

[31] THE P75 NEUROTROPHIN RECEPTOR [J].

CHAO, MV .

JOURNAL OF NEUROBIOLOGY, 1994, 25 (11) :1373-1385

[32] Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion [J].

Chen, John W. C. ;

Bhandari, Mayank ;

Astill, David S. ;

Wilson, Thomas G. ;

Kow, Lilian ;

Brooke-Smith, Mark ;

Toouli, James ;

Padbury, Robert T. A. .

HPB, 2010, 12 (02) :101-108

[33] Neuroepithelial interactions in prostate cancer are enhanced in the presence of prostatic stroma [J].

Cornell, RJ ;

Rowley, D ;

Wheeler, T ;

Ali, N ;

Ayala, G .

UROLOGY, 2003, 61 (04) :870-875

[34] KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers [J].

Corson, TW ;

Huang, A ;

Tsao, MS ;

Gallie, BL .

ONCOGENE, 2005, 24 (30) :4741-4753

[35] Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: A structural insight [J].

Covaceuszach, S ;

Cattaneo, A ;

Lamba, D .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 58 (03) :717-727

[36]

Cowan WK, 1997, J PATHOL, V182, P29, DOI 10.1002/(SICI)1096-9896(199705)182:1<29::AID-PATH820>3.0.CO

[37]

2-#

[38] Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach [J].

Dai, Hong ;

Li, Rile ;

Wheeler, Thomas ;

Ozen, Mustafa ;

Ittmann, Michael ;

Anderson, Marcus ;

Wang, Yu ;

Rowley, David ;

Younes, Mamoun ;

Ayala, Gustavo E. .

HUMAN PATHOLOGY, 2007, 38 (02) :299-307

[39] Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer [J].

Dang, Chengxue ;

Zhang, Yong ;

Ma, Qingyong ;

Shimahara, Yasuyuki .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (05) :850-858

[40] NGF receptor TrkAd5: therapeutic agent and drug design target [J].

Dawbarn, D. ;

Fahey, M. ;

Watson, J. ;

Tyler, S. ;

Shoemark, D. ;

Sessions, R. ;

Zhang, R. ;

Brady, L. ;

Willis, C. ;

Allen, S. J. .

BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 :587-590

← 1 2 3 4 5 6 7 8 9 10 →